Related Experiment Videos
Adverse impact of hypertension on diabetic recipients of transplanted kidneys
Insights
Hypertension significantly impacts kidney transplant recipients. Managing blood pressure post-transplant is crucial for improving patient survival and maintaining kidney graft function in diabetic individuals.
Area of Science:
- Nephrology
- Transplantation Immunology
- Diabetology
Background:
- Diabetic kidney disease is a leading cause of end-stage renal disease.
- Kidney transplantation is a common treatment for diabetic nephropathy.
- Hypertension is a prevalent comorbidity in diabetic patients and a known risk factor for graft dysfunction.
Purpose of the Study:
- To assess the impact of hypertension on patient and allograft survival in diabetic kidney transplant recipients.
- To determine if achieving normotension post-transplant improves outcomes.
- To evaluate the association between persistent hypertension and graft function.
Main Methods:
- Retrospective chart analysis of 60 diabetic kidney transplant recipients.
- Assessment of hypertension status pre- and post-transplantation.
- Evaluation of patient survival, allograft survival, and renal function (serum creatinine).
Main Results:
- Hypertension was present in 81% of recipients.
- Patients who became normotensive post-transplant had better outcomes (all functioning allografts, one death).
- Persistent hypertension was linked to higher mortality (48%) and graft loss (35%).
- Hypertensive recipients had poorer renal function (mean creatinine 3.1 mg/dl) compared to non-hypertensive recipients (1.6 mg/dl) at 21 months.
Conclusions:
- Hypertension is a significant risk factor for both patient and allograft survival in diabetic kidney transplant recipients.
- Effective blood pressure management is essential for optimizing outcomes after kidney transplantation in this population.
- Controlling hypertension may improve long-term graft function and reduce mortality.
Abstract:
The effect of hypertension on patient and allograft survival in 60 diabetic recipients of transplanted kidneys was assessed by retrospective chart analysis. Hypertension was present in 81% of recipients. Of eight of these patients who became normotensive after transplantation, all had functioning allografts and one died. By contrast, persistent hypertension after transplantation was associated with a higher mortality rate (25 of 54, 48%) and loss of kidney graft function (19 of 54, 35%). At a mean of 21 months after transplantation, living hypertensive diabetic recipients had worse renal function (mean serum creatinine of 3.1 mg/dl) than did nonhypertensive recipients (mean serum creatinine of 1.6 mg/dl). It is concluded that hypertension is a significant risk factor for diabetic patients and kidneys after transplantation.